Jeffrey Cislini's most recent trade in Revolution Medicines Inc was a trade of 3,314 Common Stock done at an average price of $199.3 . Disclosure was reported to the exchange on Sept. 16, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Revolution Medicines Inc | Jeffrey Cislini | SVP & General Counsel | Sale of securities on an exchange or to another person at price $ 199.30 per share. | 16 Sep 2026 | 3,314 | 52,541 (0%) | 0% | 199.3 | 660,491 | Common Stock |
| Revolution Medicines Inc | Jeffrey Cislini | SVP & General Counsel | Sale of securities on an exchange or to another person at price $ 195.00 per share. | 16 Sep 2026 | 52 | 55,855 (0%) | 0% | 195 | 10,140 | Common Stock |
| Revolution Medicines Inc | Jeffrey Cislini | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Aug 2026 | 29,680 | 0 | - | - | Stock Option (Right to Buy) | |
| Revolution Medicines Inc | Jeffrey Cislini | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.56 per share. | 21 Aug 2026 | 29,680 | 86,201 (0%) | 0% | 18.6 | 550,861 | Common Stock |
| Revolution Medicines Inc | Jeffrey Cislini | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.61 per share. | 21 Aug 2026 | 26,600 | 112,801 (0%) | 0% | 21.6 | 574,826 | Common Stock |
| Revolution Medicines Inc | Jeffrey Cislini | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Aug 2026 | 26,600 | 3,500 | - | - | Stock Option (Right to Buy) | |
| Revolution Medicines Inc | Jeffrey Cislini | General Counsel | Sale of securities on an exchange or to another person at price $ 209.25 per share. | 21 Aug 2026 | 25,817 | 66,261 (0%) | 0% | 209.2 | 5,402,200 | Common Stock |
| Revolution Medicines Inc | Jeffrey Cislini | General Counsel | Sale of securities on an exchange or to another person at price $ 208.37 per share. | 21 Aug 2026 | 17,323 | 92,078 (0%) | 0% | 208.4 | 3,609,573 | Common Stock |
| Revolution Medicines Inc | Jeffrey Cislini | General Counsel | Sale of securities on an exchange or to another person at price $ 211.34 per share. | 21 Aug 2026 | 4,500 | 59,221 (0%) | 0% | 211.3 | 951,038 | Common Stock |
| Revolution Medicines Inc | Jeffrey Cislini | General Counsel | Sale of securities on an exchange or to another person at price $ 207.24 per share. | 21 Aug 2026 | 3,400 | 109,401 (0%) | 0% | 207.2 | 704,603 | Common Stock |
| Revolution Medicines Inc | Jeffrey Cislini | General Counsel | Sale of securities on an exchange or to another person at price $ 212.06 per share. | 21 Aug 2026 | 3,314 | 55,907 (0%) | 0% | 212.1 | 702,761 | Common Stock |
| Revolution Medicines Inc | Jeffrey Cislini | General Counsel | Sale of securities on an exchange or to another person at price $ 210.26 per share. | 21 Aug 2026 | 2,540 | 63,721 (0%) | 0% | 210.3 | 534,072 | Common Stock |
| Revolution Medicines Inc | Jeffrey Cislini | General Counsel | Sale of securities on an exchange or to another person at price $ 156.12 per share. | 16 Jun 2026 | 2,157 | 56,521 (0%) | 0% | 156.1 | 336,749 | Common Stock |
| Revolution Medicines Inc | Jeffrey Cislini | General Counsel | Sale of securities on an exchange or to another person at price $ 99.48 per share. | 17 Mar 2026 | 1,795 | 59,681 (0%) | 0% | 99.5 | 178,567 | Common Stock |
| Revolution Medicines Inc | Jeffrey Cislini | General Counsel | Sale of securities on an exchange or to another person at price $ 97.44 per share. | 17 Mar 2026 | 1,163 | 58,518 (0%) | 0% | 97.4 | 113,323 | Common Stock |
| Revolution Medicines Inc | Jeffrey Cislini | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2026 | 32,500 | 32,500 | - | - | Stock Option (Right to Buy) | |
| Revolution Medicines Inc | Jeffrey Cislini | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2026 | 14,500 | 61,476 (0%) | 0% | 0 | Common Stock | |
| Revolution Medicines Inc | Jeffrey Cislini | General Counsel | Sale of securities on an exchange or to another person at price $ 115.60 per share. | 21 Jan 2026 | 908 | 46,976 (0%) | 0% | 115.6 | 104,965 | Common Stock |